Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period)Previous forecast published 19 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Operating profit fell below the forecast because, although the Plastic Products business became profitable, the Healthcare business made aggressive upfront investments, including opening company-operated e-commerce stores. Ordinary profit and interim net income attributable to owners of the parent significantly exceeded the forecast due to the recognition of a foreign exchange gain, among other factors.
| Item | Details |
|---|---|
| Net Sales | ¥3,200 million → ¥3,248 million（+1.5%） |
| Operating profit | ¥190 million → ¥74 million（-60.9%） |
| Ordinary income | ¥125 million → ¥213 million（+70.9%） |
| Profit attributable to owners of the parent | ¥30 million (interim net profit) → ¥110 million (interim net profit)（+268.3%） |
| Net income per share | 2.76 Yen/sen → 10.18 Yen/sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 19 May 2026 |
| Previous-period results | Net sales: ¥3,120 million; operating profit: ¥161 million; ordinary loss: ¥14 million; interim net loss attributable to owners of the parent: ¥126 million; interim loss per share: ¥11.64 |
| Reason for the revision | Operating profit fell below the forecast because, although the Plastic Products business became profitable, the Healthcare business made aggressive upfront investments, including opening company-operated e-commerce stores. Ordinary profit and interim net income attributable to owners of the parent significantly exceeded the forecast due to the recognition of a foreign exchange gain, among other factors. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating profit fell below the forecast because, although the Plastic Products business became profitable, the Healthcare business made aggressive upfront investments, including opening company-operated e-commerce stores, in anticipation of future growth. Ordinary profit and interim net income attributable to owners of the parent exceeded the forecast due to the recognition of a foreign exchange gain, among other factors. The foreign exchange gain was primarily attributable to the revaluation of foreign-currency-denominated assets and liabilities held by the Company and its overseas consolidated subsidiaries at the period-end exchange rate, reflecting fluctuations in foreign exchange rates.